Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 7:27 PM View:  | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 07-Apr-24 | Payment of Exercise | 665 | $2.29 | $1,522.85 | (2%) 34.94K to 34.27K | |
| 09-Apr-24 7:27 PM View: | Glessner Coleen EVP, Quality & Ethics, and CPL | Emergent BioSolutions, Inc. (EBS) | 07-Apr-24 | Payment of Exercise | 585 | $2.29 | $1,339.65 | (< 1%) 164.97K to 164.38K | |
| 07-Mar-24 8:31 PM View: | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 05-Mar-24 | Payment of Exercise | 346 | $3.41 | $1,179.86 | (< 1%) 35.28K to 34.94K | |
| 04-Mar-24 6:43 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 137 | $3.39 | $464.43 | (< 1%) 25.02K to 24.88K | |
| 04-Mar-24 6:42 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 684 | $3.39 | $2,318.76 | (< 1%) 159.43K to 158.74K | |
| 04-Mar-24 6:43 PM View: | Glessner Coleen EVP, Quality & Ethics, and CPL | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 381 | $3.39 | $1,291.59 | (< 1%) 165.35K to 164.97K | |
| 04-Mar-24 6:42 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 703 | $3.39 | $2,383.17 | (< 1%) 174.46K to 173.76K | |
| 04-Mar-24 6:42 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 29-Feb-24 | Payment of Exercise | 4,103 | $3.23 | $13,252.70 | (2%) 178.56K to 174.46K | |
| 04-Mar-24 6:43 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 29-Feb-24 | Payment of Exercise | 450 | $3.23 | $1,453.50 | (2%) 25.47K to 25.02K | |
| 04-Mar-24 6:42 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 29-Feb-24 | Payment of Exercise | 9,037 | $3.23 | $29,189.50 | (5%) 168.46K to 159.43K | |
| 27-Feb-24 8:30 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 23-Feb-24 | Payment of Exercise | 105 | $2.74 | $287.70 | (< 1%) 25.57K to 25.47K | |
| 27-Feb-24 8:26 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 23-Feb-24 | Payment of Exercise | 517 | $2.74 | $1,416.58 | (< 1%) 168.98K to 168.46K | |
| 27-Feb-24 8:28 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 23-Feb-24 | Payment of Exercise | 229 | $2.74 | $627.46 | (< 1%) 178.79K to 178.56K | |
| 27-Feb-24 8:26 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 21-Feb-24 | Disposition | 4,012 | $2.71 | $10,872.50 | (2%) 172.99K to 168.98K | |
| 14-Nov-23 7:27 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 13-Nov-23 | Payment of Exercise | 566 | $1.82 | $1,030.12 | (2%) 26.14K to 25.57K | |
| 14-Nov-23 7:28 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 11-Nov-23 | Payment of Exercise | 413 | $2.00 | $826.00 | (< 1%) 179.21K to 178.79K | |
| 14-Nov-23 7:26 PM View: | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 11-Nov-23 | Payment of Exercise | 632 | $2.00 | $1,264.00 | (2%) 35.92K to 35.28K | |
| 05-Oct-23 7:10 PM View: | Fowler Neal Franklin Director | Emergent BioSolutions, Inc. (EBS) | 03-Oct-23 | Grant | 118,670 | -- | -- | 100% 0 to 118.67K | |
| 05-Oct-23 7:08 PM View: | Degolyer Donald W Director | Emergent BioSolutions, Inc. (EBS) | 03-Oct-23 | Grant | 118,670 | -- | -- | 100% 0 to 118.67K | |
| 24-Jul-23 8:29 AM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 08-Jul-23 | Payment of Exercise | 85 | -- | -- | (< 1%) 26.23K to 26.14K | |
| 13-Jun-23 10:00 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 09-Jun-23 | Grant | 13,847 | -- | -- | 112% 12.38K to 26.23K | |
| 13-Jun-23 10:00 PM View: | Kramer Robert President and CEO Director | Emergent BioSolutions, Inc. (EBS) | 09-Jun-23 | Grant | 212,308 | -- | -- | 72% 293.75K to 506.06K | |
| 24-Jul-23 8:28 AM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 02-Jun-23 | Sale (Planned) | 1,830 | $8.35 | $15,280.50 | (4%) 51.8K to 49.97K | |
| 30-May-23 7:03 PM View: | Dayal Sujata Tyagi Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 286% 11.85K to 45.7K | |
| 30-May-23 7:09 PM View: | White Marvin L Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 198% 17.1K to 50.95K | |
| 30-May-23 7:09 PM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 172% 19.65K to 53.5K | |
| 30-May-23 7:08 PM View: | Hauer Jerome M Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 143% 23.66K to 57.51K | |
| 30-May-23 7:05 PM View: | Katkin Keith Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 394% 8.6K to 42.44K | |
| 30-May-23 7:04 PM View: | Harsanyi Zsolt Chairman Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 89% 38.05K to 71.9K | |
| 24-Jul-23 8:28 AM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Sale (Planned) | 1,700 | $8.38 | $14,246.00 | (3%) 53.5K to 51.8K | |
| 30-May-23 7:06 PM View: | Richard Ronald Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 171% 19.84K to 53.68K | |
| 30-May-23 7:07 PM View: | Sullivan Louis Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 63% 53.42K to 87.27K | |
| 10-Apr-23 7:41 PM View: | Glessner Coleen EVP, Quality & Ethics, and CPL | Emergent BioSolutions, Inc. (EBS) | 07-Apr-23 | Payment of Exercise | 480 | -- | -- | < 1% 119.67K to 120.15K | |
| 06-Mar-23 7:36 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 02-Mar-23 | Grant | 3,462 | -- | -- | 39% 8.92K to 12.38K | |
| 06-Mar-23 7:36 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 02-Mar-23 | Grant | 18,462 | -- | -- | 23% 80.68K to 99.14K | |
| 06-Mar-23 7:37 PM View: | Havey Adam EVP, Business Operations | Emergent BioSolutions, Inc. (EBS) | 02-Mar-23 | Grant | 18,462 | -- | -- | 22% 82.09K to 100.55K | |
| 06-Mar-23 7:36 PM View: | Glessner Coleen EVP, Quality & Ethics, and CPL | Emergent BioSolutions, Inc. (EBS) | 02-Mar-23 | Grant | 11,538 | -- | -- | 11% 108.14K to 119.67K | |
| 06-Mar-23 7:35 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 02-Mar-23 | Grant | 18,462 | -- | -- | 21% 86.9K to 105.36K | |
| 06-Mar-23 7:37 PM View: | Kramer Robert President and CEO Director | Emergent BioSolutions, Inc. (EBS) | 02-Mar-23 | Grant | 57,693 | -- | -- | 24% 236.06K to 293.75K | |
| 02-Mar-23 2:43 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 371 | $12.38 | $4,592.98 | (4%) 9.29K to 8.92K | |
| 02-Mar-23 2:42 PM View: | Strei Katherine EVP, Chief HR Officer | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 690 | $12.38 | $8,542.20 | (1%) 63.51K to 62.82K | |
| 02-Mar-23 2:43 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 1,005 | $12.38 | $12,441.90 | (1%) 87.9K to 86.9K | |
| 02-Mar-23 2:42 PM View: | Kramer Robert President and CEO Director | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 3,226 | $12.38 | $39,937.90 | (3%) 106.52K to 103.3K | |
| 02-Mar-23 2:43 PM View: | Saran Atul EVP, Chief Strat & Dev Officer | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 971 | $12.38 | $12,021.00 | (1%) 87.62K to 86.64K | |
| 02-Mar-23 2:42 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 1,074 | $12.38 | $13,296.10 | (6%) 17.98K to 16.91K | |
| 02-Mar-23 2:41 PM View: | Havey Adam EVP, Business Operations | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 998 | $12.38 | $12,355.20 | (3%) 34.92K to 33.93K | |
| 27-Feb-23 8:23 PM View: | Saran Atul EVP, Chief Strat & Dev Officer | Emergent BioSolutions, Inc. (EBS) | 24-Feb-23 | Payment of Exercise | 845 | $13.71 | $11,585.00 | (< 1%) 88.46K to 87.62K | |
| 27-Feb-23 8:22 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 24-Feb-23 | Payment of Exercise | 977 | $13.71 | $13,394.70 | (5%) 18.96K to 17.98K | |
| 27-Feb-23 8:22 PM View: | Havey Adam EVP, Business Operations | Emergent BioSolutions, Inc. (EBS) | 24-Feb-23 | Payment of Exercise | 812 | $13.71 | $11,132.50 | (2%) 34.49K to 33.68K | |
| 27-Feb-23 8:24 PM View: | Strei Katherine EVP, Chief HR Officer | Emergent BioSolutions, Inc. (EBS) | 24-Feb-23 | Payment of Exercise | 654 | $13.71 | $8,966.34 | (1%) 64.17K to 63.51K |
